Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction

BackgroundHeart failure with preserved ejection fraction (HFpEF) has grown to become the dominant form of heart failure worldwide. However, no unequivocally effective treatment for HFpEF has been identified in clinical trials. In this study, we report that Astragaloside IV (AS-IV) can be used to tre...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiao Wang, Xinting Chen, Yuting Wang, Xinyu He, Lan Li, Xiaodan Wang, Yuting Huang, Guanwei Fan, Jingyu Ni
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-11-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	HFpEF astragaloside IV inflammation metabolism mitochondria
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1467132/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!